Canaccord initiated coverage of Scholar Rock (SRRK) with a Buy rating and $62 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRRK:
- Scholar Rock price target raised to $57 from $54 at Jefferies
- De-Risked Regulatory Path and Manufacturing Readiness Underpin Buy Rating on Apitegromab
- Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!
- Scholar Rock price target raised to $58 from $51 at BofA
- Apitegromab: Strengthened Regulatory Position and Dual-Site Strategy De-Risk Approval and Commercialization